MC EXCLUSIVE GI Council finalises clinical admission protocols amid insurer-hospital tariff friction

Healthcare

• Health insurers to adopt evidence-based protocols for hospital admissions
• New guidelines cover 7 common infectious diseases post-monsoon
• Protocols aim to cut unnecessary hospital stays and clarify admission criteria.

Did our AI summary help?

India’s health insurance industry is set to introduce evidence-based clinical protocols to govern hospital admissions, a move that comes amid tensions with private hospitals over tariffs and cashless services.

These protocols are intended to clearly define what clinically warrants hospitalisation and what does not, sources familiar with the matter said.

The General Insurance Council (GIC) has circulated and finalised standard treatment and admission guidelines for seven of the country’s most common infectious diseases, following extensive consultations with healthcare providers, sources said.

During a recent Q3 earning call, Niva Bupa Health Insurance managing director and chief executive officer Krishnan Ramachandran said the need for standard admission criteria stems from a recurring pattern insurers have observed: after every monsoon season, hospitalisation and health insurance claims related to seasonal infections spike sharply because there is no clear, industry-wide definition of what warrants inpatient care.

“This ambiguity has historically made it difficult for insurers to determine when a case genuinely requires hospitalisation versus when it can be safely managed on an outpatient basis, which is a gap that the new protocols are intended to address,” he said.

He declined to share data on the rise in claims or the quantum of amounts, saying the focus was "on admission necessity rather than claim values"/

7 common illnesses

The GI Council protocol targets seven of the most common infectious conditions that drive post-monsoon hospital utilisation and claim frequency.

The diseases, according to the draft, typically include vector-borne diseases such as dengue, malaria and chikungunya; water- and food-borne illnesses like typhoid and gastroenteritis; leptospirosis -- a bacterial infection associated with flood-related exposure; and viral febrile illnesses that often present after rains.

Together, these diseases account for the bulk of seasonal infectious presentations in India’s healthcare system, particularly during and after the monsoon months.

The guidelines are intended to be adopted across the healthcare ecosystem, including by hospitals, treating clinicians, insurers, third-party administrators (TPAs) and claims managers, creating a common clinical reference point for determining when hospitalisation is medically warranted and when care can be safely managed outside the inpatient setting.

Queries sent to hospital bodies, including the Association of Healthcare Providers –India (AHPI), seeking confirmation on whether they are onboard with the framework remained unanswered until the time of publication.

Point of friction

The move comes at a time of intense friction between insurers and hospital bodies such as the AHPI, which has repeatedly threatened to suspend cashless services for policyholders of major insurers over what it says are outdated, unviable tariffs.

AHPI and affiliated forums have accused insurers of cartel-like behaviour by enforcing a common empanelment and standard tariff framework that suppresses hospital pricing, a charge insurers reject as “unilateral” and damaging to cashless access for patients. (https://www.moneycontrol.com/news/business/personal-finance/relief-for-patients-ahpi-withdraws-advisory-to-stop-cashless-services-for-bajaj-allianz-13499545.html)

Industry practitioners privately acknowledge that the tariff dispute, however, exposed a deeper problem -- the absence of clear clinical standards governing when hospitalisation is appropriate.

Without uniform treatment norms, insurers say they have struggled to rationalise claims, while hospitals have pushed for higher reimbursement rates on the basis of clinical judgment.

The resulting deadlocks have led to cashless service suspensions, public complaints by hospitals urging insurers to reinstate uninterrupted access for patients, and interventions by the finance ministry and regulators pressing for standardisation across the ecosystem.

Sources say unlike tariff negotiations, these guidelines are evidence driven, rooted in medicine rather than commercial calculus and not tied to reimbursement amounts.

Ramachandran said during earnings call that the draft has been discussed with more than 10,000-15,000 doctors and hospitals nationwide and refined based on provider feedback before finalisation.

The initiative would tackle the real inefficiency in healthcare utilisation: unwarranted admissions, he said.

“Infections such as dengue historically saw widespread hospitalisation post-monsoon despite many cases being safely managed on an outpatient basis. Under the new protocols, an admission is justified only where clinical parameters, not precautionary practice, indicate necessity,” he said.

The result will be fewer avoidable inpatient stays, a reduction in claim incidence, and a system that emphasises appropriate care over cost disputes.

“This is about when care should be delivered in a hospital at all,” said another senior industry executive. “It removes ambiguity on necessity; now clinical criteria, not interpretation, will determine admissions.”

The timing dovetails with broader regulatory signals. The finance ministry recently urged hospitals and insurers to expedite standardised treatment protocols and common empanelment norms to make healthcare more affordable and accessible. (https://www.moneycontrol.com/news/business/finance-ministry-asks-hospitals-insurers-to-make-healthcare-affordable-and-accessible-for-policyholders-13674827.html)

Hospitals must be fairly compensated for rising costs and that one-size-fits-all models risk undermining quality care. But insurers counter that clinical evidence, not price alone, should drive the terms of coverage and cashless access.

Sources also said tariff frameworks still remain embroiled in negotiation and occasional standoffs.

However, by anchoring these standards in scientific practice rather than commercial calculus, insurers hope to build legitimacy and shift the narrative from commodity pricing to clinical appropriateness.